Moderna swung to profit and raised its revenue growth forecast to 15% to 25%
Third-quarter revenue rose 29% from a year earlier as international COVID vaccine sales climbed; the prior outlook was up to 10% growth
We haven't written up this one. Quartz has the full story — the link below goes straight to it.